Depression Mild study: Education
Official title Treating Major Depression With Yoga Mono-therapy
ClinicalTrials.gov ID: NCT06091527
What this study is testing
- What it's testing
- The study aims to find out if doing yoga alone can improve symptoms of mild to moderate depression.
- Who it's for
- The study is looking for adults who have been diagnosed with mild to moderate major depression.
- What's involved
- Participants will be assigned to either a 12-week yoga program or a control group that receives general health education.
- Time commitment
- The study lasts 12 weeks and involves attending sessions at the Zuckerberg San Francisco General Hospital.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- 18 years of age or older
- Able to give voluntary, informed consent
- English-speaking
- Diagnosis of clinical depression
You likely can't join if
- Current use of antidepressant medication
- Current engagement in psychotherapy
- Current pregnancy
- Significant medical issues interfering with yoga practice
The study team makes the final eligibility decision.
Where it is enrolling
- San Francisco, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at San Francisco, California, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.